MorphoSys Surges on Novartis Takeover Speculation: Munich Mover

MorphoSys AG, a German biotechnology company, rose to the highest since March 2001 on speculation that its shareholder Novartis AG may make a bid for the company.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.